Logos Global Management LP Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$854.6B
Holdings
47
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (47 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | IDYAIDEAYA BIOSCIENCES INC | 3,000,000 | $77.1B | 9.02% | |
| 2 | JANXJANUX THERAPEUTICS INC | 1,250,000 | $66.9B | 7.83% | |
| 3 | RVMDREVOLUTION MEDICINES INC | 1,450,000 | $63.4B | 7.42% | |
| 4 | CYTKCYTOKINETICS INC | 900,000 | $42.3B | 4.95% | |
| 5 | VERAVERA THERAPEUTICS INC | 875,000 | $37.0B | 4.33% | |
| 6 | BNTXBIONTECH SE | 300,000 | $34.2B | 4.00% | |
| 7 | MRUSMERUS N V | 750,000 | $31.5B | 3.69% | |
| 8 | ERASERASCA INC | 12,500,000 | $31.4B | 3.67% | |
| 9 | IM8NINSMED INC | 450,000 | $31.1B | 3.64% | |
| 10 | OCULOCULAR THERAPEUTIX INC | 3,500,000 | $29.9B | 3.50% | |
| 11 | NBIXNEUROCRINE BIOSCIENCES INC | 200,000 | $27.3B | 3.19% | |
| 12 | DSGNDESIGN THERAPEUTICS INC | 4,217,627 | $26.0B | 3.04% | |
| 13 | PCVXVAXCYTE INC | 300,000 | $24.6B | 2.87% | |
| 14 | AKROAKERO THERAPEUTICS INC | 800,000 | $22.3B | 2.60% | |
| 15 | JAZZJAZZ PHARMACEUTICALS PLC | 175,000 | $21.6B | 2.52% | |
| 16 | GPCRSTRUCTURE THERAPEUTICS INC | 700,000 | $19.0B | 2.22% | |
| 17 | OLMAOLEMA PHARMACEUTICALS INC | 3,208,875 | $18.7B | 2.19% | |
| 18 | 2L9BLUEPRINT MEDICINES CORP | 200,000 | $17.4B | 2.04% | |
| 19 | TVTXTRAVERE THERAPEUTICS INC | 1,000,000 | $17.4B | 2.04% | |
| 20 | APLSAPELLIS PHARMACEUTICALS INC | 500,000 | $16.0B | 1.87% | |
| 21 | SLNOSOLENO THERAPEUTICS INC | 350,000 | $15.7B | 1.84% | |
| 22 | ALKSALKERMES PLC | 500,000 | $14.4B | 1.68% | |
| 23 | APGEAPOGEE THERAPEUTICS INC | 300,000 | $13.6B | 1.59% | |
| 24 | ARVNARVINAS INC | 700,000 | $13.4B | 1.57% | |
| 25 | ANNXANNEXON INC | 2,550,000 | $13.1B | 1.53% | |
| 26 | IRONDISC MEDICINE INC | 200,000 | $12.7B | 1.48% | |
| 27 | SYRESPYRE THERAPEUTICS INC | 500,000 | $11.6B | 1.36% | |
| 28 | EWTXEDGEWISE THERAPEUTICS INC | 400,000 | $10.7B | 1.25% | |
| 29 | DYNDYNE THERAPEUTICS INC | 450,000 | $10.6B | 1.24% | |
| 30 | PLRXPLIANT THERAPEUTICS INC | 750,000 | $9.9B | 1.16% | |
| 31 | DRUGBRIGHT MINDS BIOSCIENCES INC | 245,000 | $8.8B | 1.03% | |
| 32 | YMABUSDY-MABS THERAPEUTICS INC | 1,000,000 | $7.8B | 0.92% | |
| 33 | IMVTIMMUNOVANT INC | 300,000 | $7.4B | 0.87% | |
| 34 | GONGERON CORP | 2,000,000 | $7.1B | 0.83% | |
| 35 | ACRSACLARIS THERAPEUTICS INC | 2,222,222 | $5.5B | 0.64% | |
| 36 | TRVITREVI THERAPEUTICS INC | 1,250,000 | $5.2B | 0.60% | |
| 37 | CATBUSDASTRIA THERAPEUTICS INC | 500,000 | $4.5B | 0.52% | |
| 38 | UNCYUNICYCIVE THERAPEUTICS INC | 5,078,927 | $4.0B | 0.47% | |
| 39 | AVTEAEROVATE THERAPEUTICS INC | 1,400,000 | $3.7B | 0.43% | |
| 40 | RAPPRAPPORT THERAPEUTICS INC | 208,910 | $3.7B | 0.43% | |
| 41 | ATYRATYR PHARMA INC | 1,000,000 | $3.6B | 0.42% | |
| 42 | ALLKGUSDALLAKOS INC | 2,900,000 | $3.5B | 0.41% | |
| 43 | ELVNENLIVEN THERAPEUTICS INC | 140,000 | $3.1B | 0.37% | |
| 44 | SEPNSEPTERNA INC | 134,202 | $3.1B | 0.36% | |
| 45 | ARTVARTIVA BIOTHERAPEUTICS INC | 145,089 | $1.5B | 0.17% | |
| 46 | GLYCEURGLYCOMIMETICS INC | 5,400,000 | $1.3B | 0.16% | |
| 47 | NUVB/WSNUVATION BIO INC | 66,666 | $15.3M | 0.00% |